The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma

The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma

Abstract To evaluate the clinical value of polyethylene glycolized recombinant human granulocyte-stimulating factor (PEG-rhG-CSF) for hematopoietic reconstitution after autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM) patients. This study analyzed data from 70 N...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruiqi Wang, Hao Tian, Zhenxing Zhu, Dan Cong, Yuansong Bai, Wenlong Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Recombinant human granulocyte stimulating factor
Newly diagnosed multiple myeloma
Autologous stem cell transplantation
Hematopoietic reconstitution
Online Access:https://doi.org/10.1038/s41598-025-15360-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items